Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Moph: Prevention Guidance following the Storm Repercussions

 
The Information office of the Ministry of Public Health issued the following statement:

In anticipation of the upcoming storms that will hit Lebanon, and in the light of its awareness-raising tasks, the Ministry of Public Health issued the following guidelines to ensure the safety of the citizens.
  • Follow the safety standards while using heating appliances, in particular at night to prevent any gas leak or fire.
  • Equip your houses with fire extinguishers.
  • Avoid moving between cold and hot areas and drink plenty of fluids to prevent dehydration.
  • People with heart diseases, asthma or obstructive pulmonary are advised not to leave home to avoid exposure to cold air that might cause health problems.
  • Store sufficient quantities of medicines for all the period of the storm.
For more information on the protection from accidents caused by heating appliances, read the following guidelines on children protection.
 
Heating:
  • When using an electric heater, check the electric cables to avoid any electrical fire
  • When using a gas heater, check the gas hose for any gas leak
  • When using  coal – wood – diesel heaters, the following should be considered:
 
  • Don’t allow children to contact or play with the flame to prevent burns, accidents and suffocation
  • Equip your houses with fire extinguishers, fire blanket and  a smoke detector (if possible)
  • Keep the heater far from diesel tanks
  • Ensure flammable items are kept away from the heating appliances (curtains, blankets…)
  • Don’t keep the clothes close to heating appliances to dry them 
Personal prevention tips:
  • Avoid exposing your back and neck to cold air and wear suitable clothes
  • Avoid moving between cold and hot areas
  • Drink plenty of water and fluids to prevent dehydration
  • Turn off your home’s electricity in the event of flooded home 
People with chronic diseases:
  • People with asthma or obstructive pulmonary are advised not to leave home during the storm
  • People with heart diseases are advised to stay home since cold air can cause vessels/ coronary arteries to narrow, which can lead to a pain in the chest
  • Store sufficient quantities of medicines for all the period of the storm. 
Tips for children

Clothing:
  • Dress your infants and children in warm clothes, in particular when going outside. Don’t forget winter accessories such as gloves and hat. Dress babies and young children in one more layer of clothing than an adult would wear in the same conditions.
  • blankets, quilts, pillows can cause Sudden Infant death syndrome 
  • Hypothermia
  • Hypothermia is a drop in body temperature caused by exposure to cold temperatures. It usually occurs when children play outside in extremely cold weather without wearing appropriate clothes or when clothes are wet.
  • Symptoms are shivering, mumbling, very low energy and even loss of consciousness. In such a case, bring the child indoors, remove any wet clothes, wrap with blanket or warm clothes and contact the doctor if need be. 
Frostbite
Frostbite occurs when cold causes extremities to freeze, such as fingers, feet, ears and nose which may become white or blue, or may itch or burn.

In case of frostbite, the child should be brought indoors and his injured parts should be put in warn water. Warm towels can also be applied to nose, ears and lips. Do not to rub the frozen area surfaces. A few minutes later, give the child warm fluids to drink. If numbness persisted more than a couple of minutes, contact your doctor.
 
    ...
    8
ATC Name B/G Ingredients Dosage Form Price
R06AX27 RINA 5 G Desloratadine - 5mg 0.5mg/ml Tablet, film coated 134,384 L.L
M01AE51 RELI-FLU G Ibuprofen - 200mg, Pseudoephedrine HCl - 30mg Tablet, film coated 139,504 L.L
B01AF01 RIBAVAN G Rivaroxaban - 2.5mg 2.5mg Tablet, film coated 3,199,625 L.L
B01AF01 RIBAVAN G Rivaroxaban - 15mg 15mg Tablet, film coated 1,343,843 L.L
B01AF01 RIXALTA 15 G Rivaroxaban - 15mg 15mg Tablet, film coated 1,164,664 L.L
B01AF01 RIBAVAN G Rivaroxaban - 20mg 20mg Tablet, film coated 1,343,843 L.L
B01AF01 RIXALTA 20 G Rivaroxaban - 20mg 20mg Tablet, film coated 1,164,664 L.L
B02BX05 REVOLADE B Eltrombopag Olamine - 50mg 50mg Tablet, film coated L.L
B01AF01 RIBAVAN G Rivaroxaban - 10mg 10mg Tablet, film coated 959,888 L.L
B01AF01 RIXALTA 10 G Rivaroxaban - 10mg 10mg Tablet, film coated 671,921 L.L
A02BC04 RAMEP G Rabeprazole (sodium) - 10mg 10mg Tablet, gastroresistant 795,310 L.L
A02BC04 RAMEP G Rabeprazole (sodium) - 20mg 20mg Tablet, gastroresistant 499,046 L.L
R03DC03 ROMILAST G Montelukast (sodium) - 5mg 5mg Tablet, mouth dissolving 518,723 L.L
R03DC03 ROMILAST G Montelukast (sodium) - 4mg 4mg Tablet, mouth dissolving 405,840 L.L
N05AX08 RISCHOTIC OD 1 G Risperidone - 1mg 1mg Tablet, orally disintegrating 371,157 L.L
N05AX08 RISCHOTIC OD 2 G Risperidone - 2mg 2mg Tablet, orally disintegrating 371,157 L.L
N05AX08 RISCHOTIC OD 3 G Risperidone - 3mg 3mg Tablet, orally disintegrating 605,369 L.L
N05AX08 RISCHOTIC OD 4 G Risperidone - 4mg 4mg Tablet, orally disintegrating 605,369 L.L
N06AX11 REMERON SOLTAB B Mirtazapine - 30mg 30mg Tablet, orodispersible 1,486,290 L.L
C01EB18 RANEXA B Ranolazine - 375mg 375mg Tablet, prolonged release 3,985,837 L.L
C01EB18 RANEXA B Ranolazine - 500mg 500mg Tablet, prolonged release 3,985,837 L.L
C01EB18 RANEXA B Ranolazine - 750mg 750mg Tablet, prolonged release 3,985,837 L.L
C03BA11 RAWEL SR G Indapamide - 1.5mg 1.5mg Tablet, prolonged release 362,837 L.L
L04AA44 RINVOQ B Upadacitinib - 15mg 15mg Tablet, prolonged release 45,469,094 L.L
N03AE01 RIVOTRIL B Clonazepam - 0.5mg 0.5mg Tablet, scored 403,153 L.L
N03AE01 RIVOTRIL B Clonazepam - 2mg 2mg Tablet, scored 503,941 L.L
C05CX REPARIL B Aescine - 20mg 20mg Tablet, sugar coated 510,660 L.L
    ...
    8
Sitemap
© Copyrights reserved to Ministry of Public Health 2025